±«ÓãÖ±²¥

Company to run a Phase 2 clinical study with LAU-7b, a pro-resolving drug with potential antiviral properties against coronavirus

Classified as: anti-viral drugs, Clinical trials, press release, covid-19, therapies
Published on: 9 Apr 2020
Back to top